Basilar artery occlusion
diseaseOn this page
Summary
Basilar artery occlusion (MONDO:0001715) is a disease and 24 clinical trials. Top therapeutic interventions include tenecteplase and minocycline. A subtype of occlusion precerebral artery — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Clinical trials: 24
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | basilar artery occlusion |
| Mondo ID | MONDO:0001715 |
| DOID | DOID:13446 |
| SNOMED CT | 195180004 |
| UMLS | C0265098 |
| MedGen | 539076 |
| Anatomy (UBERON) | UBERON:0001633 |
| Is cancer (heuristic) | no |
Disease family
This is a subtype of occlusion precerebral artery. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › nervous system disorder › central nervous system disorder › brain disorder › cerebrovascular disorder › occlusion precerebral artery › basilar artery occlusion
Related subtypes (2): vertebral artery occlusion, carotid artery occlusion
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 24.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 17 |
| PHASE4 | 2 |
| PHASE3 | 2 |
| PHASE2/PHASE3 | 1 |
| PHASE2 | 1 |
| EARLY_PHASE1 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT05512910 | PHASE4 | ACTIVE_NOT_RECRUITING | Minocycline for Acute Ischemic Stroke Undergoing Endovascular Treatment Due to Basilar Artery Occlusion (MIST-B) |
| NCT07203625 | PHASE4 | RECRUITING | Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours |
| NCT05105633 | PHASE2/PHASE3 | RECRUITING | Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke |
| NCT05827042 | PHASE3 | RECRUITING | Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion |
| NCT05701956 | PHASE3 | COMPLETED | Intravenous Tenecteplase Plus EVT Versus EVT Alone on 4.5 to 24 Hours After Basilar Artery Occlusion |
| NCT05580822 | PHASE2 | UNKNOWN | Additive Effects of Intra-arterial Tenecteplase for Successful Thrombectomy Due to Acute Basilar Artery Occlusion |
| NCT06489925 | EARLY_PHASE1 | NOT_YET_RECRUITING | Cerebrolysin as an Add-On Therapy to Standard Treatment of Basilar Artery Occlusion |
| NCT05320263 | Not specified | RECRUITING | Contact Aspiration Versus Stent Retriever for Recanalisation of Acute Stroke Patients With Basilar Artery Occlusion: The Posterior Circulation ASTER Randomized Trial Protocol |
| NCT05615038 | Not specified | ACTIVE_NOT_RECRUITING | A Comparison of Contact Aspiration Versus Stent Retriever for Acute Basilar Artery Occlusion |
| NCT06101667 | Not specified | RECRUITING | Efficacy and Safety of Endovascular Recanalization for Acute Basilar Artery Occlusion With Extended Time Window (ANGEL-BAO) |
| NCT06560203 | Not specified | RECRUITING | Basilar Artery Occlusion Chinese Endovascular Trial in the Extended Time Window |
| NCT06843356 | Not specified | RECRUITING | Trial of Rescue Endovascular Treatment for Progressive Acute Mild Ischemic Stroke With Basilar Artery Occlusion With Extended Time Window |
| NCT06924996 | Not specified | ENROLLING_BY_INVITATION | Efficacy and Safety of Endovascular Thrombectomy in Acute Ischemic Stroke With Posterior Circulation Large Infarct |
| NCT07046299 | Not specified | NOT_YET_RECRUITING | Basilar Artery Occlusion Chinese Endovascular Trial in Patients With Large Core Infarct |
| NCT07090941 | Not specified | RECRUITING | EVT in Acute Basilar Artery Occlusion With Large Infarction Core |
| NCT07333950 | Not specified | NOT_YET_RECRUITING | The Efficacy and Safety of Endovascular Therapy for Acute Ischemic Stroke Due to Large Core Infarction |
| NCT07345702 | Not specified | NOT_YET_RECRUITING | Basilar Artery Occlusion Chinese Endovascular Registry in Patients With Large-Core Infarct |
| NCT07390032 | Not specified | NOT_YET_RECRUITING | The Efficacy and Safety of Endovascular Treatment for Acute Mild Basilar Artery Occlusion |
| NCT01717755 | Not specified | UNKNOWN | Basilar Artery International Cooperation Study |
| NCT02737189 | Not specified | COMPLETED | Basilar Artery Occlusion Chinese Endovascular Trial |
| NCT04177615 | Not specified | UNKNOWN | Randomized Assessment of Rapid Endovascular Treatment in Basilar Artery Occlusion Stroke in 115 Hospital |
| NCT04751708 | Not specified | COMPLETED | Endovascular Treatment for Acute Basilar Artery Occlusion |
| NCT05402878 | Not specified | UNKNOWN | OUTCOME AND SAFETY OF RECANALIZATION TREATMENTS IN ISCHEMIC STROKE DUE TO ACUTE BASILAR ARTERY OCCLUSION |
| NCT05631847 | Not specified | COMPLETED | Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke |
Drugs tested across these trials (top 30)
| Molecule | Max phase | Trials referencing |
|---|---|---|
| TENECTEPLASE | 4 | 4 |
| MINOCYCLINE | 4 | 1 |
Related Atlas pages
- Drugs: Tenecteplase, Minocycline